Cadila Of India, WHO To Collaborate On Rabies Treatment
This article was originally published in PharmAsia News
Executive Summary
India's Cadila Healthcare said its Zydus Cadila arm and the World Health Organization have agreed to collaborate on a possible treatment for rabies. In a stock exchange filing, Cadila said the aim of the agreement is to develop a drug cocktail based on monoclonal antibodies to treat the disease that results from a bite by a rabid animal. WHO is to provide antibodies with the potential of neutralizing the rabies virus, along with the genetic sequences of the virus. Cadila's Zydus Research Center is to evaluate the possibility of that information leading to an adjuvant therapy. (Click here for more